News|Articles|July 22, 2024
Enhancing Clinical Trial Flexibility
Author(s)Catalyst
As drug development costs continue to escalate, sponsors are incentivized to find less expensive approaches to develop their assets. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service CRO offerings.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Worldwide Clinical Trials to Acquire Catalyst Clinical Research, Expanding Oncology and FSP Capabilities
2
How Real-World Evidence Will Change Trials Without Replacing Them
3
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
4
ACT Brief: ESG Moves Into Vendor Oversight, RWE Faces Governance Hurdles, and Roche Advances Obesity Pipeline
5